The Comparison of Second Trimester Screening Tests With the White Blood Cell Counts

Alper Tunga Özdemir; Burcu Gölcük; Rabia Bilge Özgül Özdemir; Sema Kardeşler; Fatma Eskicioğlu

E-ISSN : 2148-9696

Crescent Journal of
Medical and Biological Sciences

Main Page Aim and Scope Instructions to Authors Editorial Policies Editorial Board Authorship Agreement Form Open Access and Copyright

Apr 2016, Vol 3, Issue 2

CURRENT ISSUE ARCHIVE AHEAD OF PRINT / ACCEPTED ARTICLE MOST VIEWED ARTICLES NEWS RELATED LINKS

Advanced Search

For Author's & Reviewer's

Committee on Publication
Ethics (COPE) Flowchart

Recommendations for the Conduct

World Association of Medical Editors(WAME)

EQUATOR Resources : Reviewers

Poll

How do you find the scientific quality of the published articles on our web site?

Very good

Good

Fair

Bad

Very bad

Original Article
The Comparison of Second Trimester Screening Tests With the White Blood Cell Counts
Alper Tunga Özdemir¹, Burcu Gölcük², Rabia Bilge Özgül Özdemir³, Sema Kardeşler², Fatma Eskicioğlu⁴
¹Department of Stem Cell, Ege University, Institute of Health Sciences, Izmir, Turkey ²Department of Clinical Biochemistry, Merkezefendi State Hospital, Manisa, Turkey ³Department of Immunology and Allergy, Manisa State Hospital, Manisa, Turkey ⁴Department of Obstetrics and Gynecology, Merkezefendi State Hospital, Manisa, Turkey
CJMB 2016; 3: 040-044 Viewed : 3398 times Downloaded : 3630 times. Keywords : Blood cell count, Neural tube defects, Prenatal diagnosis, Pregnancy Trimester, Second, Trisomy 21, White blood cell
Full Text(PDF) \| Related Articles
Abstract

Objective: Our aim was to determine the possible differences in the maternal immune system by comparing white blood cells (WBCs) count with the sub-parameters in pregnant women with high-risk and no-risk for seconder trimester screening. Materials and Methods: The results of complete blood count (CBC) and second trimester screening (STS) tests made between January 2011 and September 2015 of women meeting the inclusion criteria were analyzed retrospectively. All test results of pregnant women with high-risk for trisomy 21 (n = 55), neural tube defect (NTD) (n = 45) and with no-risk (n = 55) were compared. Trisomy 18 could not be evaluated due to limited number of cases. Results: The monocyte count (P < 0.001) of T21 group were significantly increased compared to control group, but neutrophil to lymphocyte ratio (N/L) (P = 0.027), lymphocyte to monocyte ratio (L/M) (P < 0.001) and neutrophil to monocyte ratio (N/M) (P < 0.001) were significantly decreased. The WBC (P = 0.02), monocyte (P < 0.001) and lymphocyte (P < 0.001) count of NTD group were significantly increased compared to control group, but N/L (P = 0.02), L/M (P = 0.034) and N/M ratio (P < 0.001) were decreased. Conclusion: The interaction of maternal immune system with the abnormal fetus may change the compositions of peripheral blood WBC and sub-parameters. Some of these changes may increase the predictive sensitivity of STS test. Further prospective studies are needed to confirm these findings.